Wednesday, March 25, 2020 12:02:04 PM
iwasadiver,
Agreed. I Just think Linda is pleading with FDA to make even more changes objective instead of subjective where a case by case situation can give opportunity to bias and influence from outside sources not necessarily primarily tied to patient advocacy and well being but rather to purse strings. Patients and doctors want safe options which act as tools with which to work. FDA and other regulators are being asked to take this under full consideration especially where "safety is not an issue". I think that is where anyone who needs treatment, doctors and even the 800 statisticians Linda pointed to, would agree that this type of stance is long overdue and worth pleading for. Best wishes.
Agreed. I Just think Linda is pleading with FDA to make even more changes objective instead of subjective where a case by case situation can give opportunity to bias and influence from outside sources not necessarily primarily tied to patient advocacy and well being but rather to purse strings. Patients and doctors want safe options which act as tools with which to work. FDA and other regulators are being asked to take this under full consideration especially where "safety is not an issue". I think that is where anyone who needs treatment, doctors and even the 800 statisticians Linda pointed to, would agree that this type of stance is long overdue and worth pleading for. Best wishes.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
